Skip to main content
Veterinary Medicines

ZODON 264 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Clindamycin hydrochloride

Product identification

Medicine name:
ZODON 264 MG CHEWABLE TABLETS FOR DOGS
Givix Vet. 264 mg tyggetabletter
Active substance:
  • Clindamycin hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clindamycin hydrochloride
    286.70
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF01
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Cardboard box of 12 tablets containing 2 blisters of 6 tablets
  • Cardboard box of 96 tablets containing 16 blisters of 6 tablets
  • Cardboard box of 120 tablets containing 20 blisters of 6 tablets
  • Cardboard box of 240 tablets containing 40 blisters of 6 tablets
  • Cardboard box of 6 tablets containing 1 blister of 6 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 52713
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0362/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TYGGETABLETTER 264 MG)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."